FDA approves therapeutic use of insulin inhalant
Saturday, January 28, 2006 The United States Food and Drug Administration (FDA) approved the use of an inhalable form of insulin for treating both forms of diabetes in adults. The product, manufactured by Pfizer Inc. is called Exubera and is a inhaled powder form of recombinant short-acting human insulin (rDNA). Insulin is a hormone produced […]